 December 21st, 2005
FDA grants orphan-drug status to Uniplas [...more]
|
November 29th, 2005
Octapharma to operate plasma fractionation plant owned by the NSTOB, a blood transfusion service founded by the German Red Cross, in Springe, Germany [...more]
|
November 4th, 2005
The GAMPP Study: Investigation of IVIG for the Management of Multiple Sclerosis after Pregnancy [...more]
|
October 15th, 2005
Octapharma Raises $20,000 in Company Match Fund Raising Program to Aid Hurricane Victims in the US. [...more]
|
October 5th, 2005
Octapharma Stimulates Brains at the European Federation of Neurological Societies (EFNS) Congress in Athens Greece, September 17-20. [...more]
|
July 27th, 2005
New generation treatment option for von Willebrand disease (VWD) to be presented a the upcoming ISTH congress 2005 in Sydney, Australia [...more]
|
June 13th, 2005
Octagam® Post-marketing Surveillance data presented at FDA workshop [...more]
|
June 10th, 2005
Octapharma Sponsors Fun in the Sun! [...more]
|
May 9th, 2005
2004 Annual Report Released [...more]
|
April 28, 2005
Interim General Manager for Octapharma USA [...more]
|
March 18, 2005
International Launch of Octaplex at the ISICEM Congress [...more]
|
February 15, 2005
Wilate®, Octapharma’s New Generation VWF/FVIII-concentrate, Receives Registration Approval in Germany [...more]
|
January 14, 2005
Octagam - "A Real Difference" [...more]
|
January 4, 2005
Octapharma sends products to Sri Lanka and initiates company-wide fundraising effort in response to Tsumani disaster [...more]
|
